美股异动 | Tempus Pixel设备升级版获特别510(k)许可 Tempus AI(TEM.US)大涨超13%

Core Viewpoint - Tempus AI's stock surged over 13%, approaching its previous high, following the announcement of FDA approval for its updated Tempus Pixel device, marking a significant regulatory milestone in cardiac imaging [1] Group 1: Company Developments - Tempus AI announced that its updated Tempus Pixel device received special 510(k) clearance from the FDA, allowing it to be commercially used in the United States [1] - The FDA approval represents an important upgrade for the device in the cardiac imaging field, indicating progress in the company's product offerings [1] Group 2: Market Reaction - Following the FDA announcement, Tempus AI's stock price increased to $88.81, reflecting strong investor confidence and interest in the company's advancements [1]